Cargando…

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

BACKGROUND: The intestinal microbiota plays a crucial role in human health, which could affect host immunity and the susceptibility to infectious diseases. However, the role of intestinal microbiota in the immunopathology of invasive candidiasis remains unknown. METHODS: In this work, an antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mengmeng, Li, Congya, Wu, Xianan, Chen, Tangtian, Ren, Lei, Xu, Banglao, Cao, Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251893/ https://www.ncbi.nlm.nih.gov/pubmed/32460890 http://dx.doi.org/10.1186/s13054-020-02977-5

Ejemplares similares

Candidiasis in patients treated with interleukin-17 inhibitors
por: Báez-Gutierrez, Nerea, et al.
Publicado: (2021)

IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of Clostridioides difficile infection
por: Xu, Banglao, et al.
Publicado: (2021)

Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis
por: Pietrella, Donatella, et al.
Publicado: (2011)

Interleukin-34: an important modifier in the pathogenesis of influenza pneumonia
por: Xu, Banglao, et al.
Publicado: (2021)

Vaccines in the treatment of invasive candidiasis
por: Wang, Xiao-juan, et al.
Publicado: (2015)

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
por: Calcinotto, Arianna, et al.
Publicado: (2018)

Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab)
por: Picciani, Bruna Lavinas Sayed, et al.
Publicado: (2021)

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
por: Davidson, Linda, et al.
Publicado: (2021)

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
por: Armstrong, April W., et al.
Publicado: (2022)

Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis
por: Burgess, Stacey L., et al.
Publicado: (2014)

Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37
por: van de Veerdonk, Frank L., et al.
Publicado: (2015)

Diagnosis of invasive candidiasis in the ICU
por: Eggimann, Philippe, et al.
Publicado: (2011)

Risk prediction for invasive candidiasis
por: Ahmed, Armin, et al.
Publicado: (2014)

Breakthrough Invasive Candidiasis in Children
por: Dong, Sara, et al.
Publicado: (2017)

Diagnosis and Treatment of Invasive Candidiasis
por: Barantsevich, Natalia, et al.
Publicado: (2022)

A Novel Interleukin 17 Receptor A Mutation in a Child with Chronic Mucocutaneous Candidiasis and Staphylococcal Skin Infections
por: Yakıcı, Nalan, et al.
Publicado: (2023)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

Interleukin 17 in early invasive breast cancer
por: Popović, Marina, et al.
Publicado: (2023)

Epidemiology and antifungal resistance in invasive candidiasis
por: Rodloff, AC, et al.
Publicado: (2011)

Invasive Candidiasis in Non-Hematological Patients
por: Mikulska, Malgorzata, et al.
Publicado: (2011)

Epidemiology and risk factors for invasive candidiasis
por: Yapar, Nur
Publicado: (2014)

Molecular Methods for the Diagnosis of Invasive Candidiasis
por: Camp, Iris, et al.
Publicado: (2020)

COVID-19 associated invasive candidiasis
por: Al-Hatmi, Abdullah M.S., et al.
Publicado: (2021)

Invasive Candidiasis Associated with Adenovirus Pneumonia
por: Liyanage, Guwani, et al.
Publicado: (2021)

Invasive Candidiasis in Children: Challenges Remain
por: Baalaaji, Mullai
Publicado: (2022)

An experimental porcine model of invasive candidiasis
por: Krifors, Anders, et al.
Publicado: (2023)

Antifungal stewardship in critical care: Implementing a diagnostics-driven care pathway in the management of invasive candidiasis
por: Hare, D., et al.
Publicado: (2020)

Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis
Publicado: (1992)

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
por: Huppler, Anna R, et al.
Publicado: (2012)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

The role of interleukin-17 in asthma: a protective response?
por: Hynes, Gareth M., et al.
Publicado: (2020)

Use of Recombinant Antigens for the Diagnosis of Invasive Candidiasis
por: Laín, Ana, et al.
Publicado: (2008)

Treatment of invasive candidiasis in the elderly: a review
por: Flevari, Aikaterini, et al.
Publicado: (2013)

Candida and Host Determinants of Susceptibility to Invasive Candidiasis
por: Lionakis, Michail S., et al.
Publicado: (2013)

Invasive candidiasis and oral manifestations in premature newborns
por: Tinoco-Araujo, José Endrigo, et al.
Publicado: (2013)

Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children
por: Steinbach, William J.
Publicado: (2016)

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy
por: Dekkers, B. G. J., et al.
Publicado: (2018)

Treatment of Invasive Candidiasis: A Narrative Review
por: Ben-Ami, Ronen
Publicado: (2018)

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?
por: Raineri, Santi Maurizio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_174tgnptr50irqefh9l5t91ppa